Avande, Inc. v. Shawn Evans

Court of Chancery of Delaware·Decided August 13, 2019·No. C.A. No. 2018-0203-AGB·Published

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

AVANDE, INC., a Delaware corporation )

)

Plaintiff, )

)

v. ) C.A. No. 2018-0203-AGB )

SHAWN EVANS and DC RISK ) SOLUTIONS, INC., )

)

Defendants. )

MEMORANDUM OPINION

Date Submitted: May 21, 2019 Date Decided: August 13, 2019

Thad J. Bracegirdle and Julie M. O’Dell, WILKS, LUKOFF & BRACEGIRDLE, LLC, Wilmington, Delaware; Jerome R. Bowen, BOWEN LAW OFFICES, Las Vegas, Nevada; Attorneys for Plaintiff Avande, Inc..

Sean J. Bellew, BELLEW, LLC, Wilmington, Delaware; Attorney for Defendants Shawn Evans and DC Risk Solutions, Inc.

BOUCHARD, C.

This post-trial decision resolves various claims that Avande, Inc., a privately held medical claims management company, brought against its former CEO and director Shawn Evans and a company he owns, DC Risk Solutions, Inc. Avande contends that Evans breached his duty of loyalty by engaging in self-interested transactions, authorizing improper expenditures of company funds, and failing to maintain appropriate documentation of company expenditures. For this, Avande seeks over $5.3 million of damages, which equals approximately 45% of all the expenses Avande incurred to operate its business from its inception in 2013 until Evans was terminated as CEO in February 2018.

As explained below, the court concludes that Avande is entitled to damages, but only in the amount of $21,817.70, and to an accounting of payments that Avande made to DC Risk Solutions, Inc., which it quantifies to be $235,845.83 Defendants are entitled to judgment in their favor on all other claims. I. BACKGROUND The facts recited in this opinion are my findings following a three-day trial held in February 2019. The record includes live testimony from five witnesses, approximately 450 exhibits, stipulations of fact in the Pre-Trial Stipulation and Order (“PTO”), and twelve depositions.1

1 Two of the trial witnesses have the same last name: defendant Shawn Evans and an outside accountant Avande hired named Rick Evans. This decision refers to Shawn Evans as “Evans” and to Rick Evans by his full name.

A. The Players Avande, Inc is a privately held Delaware corporation that was formed on February 23, 2016, before which time its business was pursued through Avande, LLC, a Delaware limited liability company that was formed in April 2013. 2 For simplicity, unless otherwise noted, the court refers to both entities together as “Avande” or the “Company.” Avande’s principal place of business is in North Augusta, South Carolina.3 Defendant Shawn Evans is a resident of San Francisco, California who served as a director and the Chief Executive Officer of Avande, Inc. from February 23, 2016 until February 15, 2018.4 Evans previously served as the Managing Member and Chief Executive Officer of Avande, LLC.5 Evans is the owner of defendant DC Risk Solutions, Inc. (“DC Risk”), an insurance brokerage and consulting firm based in San Francisco, California, where it is incorporated.6 Two other individuals prominent in this action are Dr. Norman Kato and Mehmet Ergun, who both served as managers of Avande LLC and then as directors

2 PTO ¶¶ 1, 3; JX 14.

3 PTO ¶ 1.

4 PTO ¶¶ 7-8.

5 PTO ¶ 9.

6 PTO ¶ 10; Tr. 5 (Evans).

of Avande, Inc.7 Kato served as Avande, Inc.’s Chief Medical Officer from its inception through February 15, 2018, and is currently Chief Executive Officer and a director.8 Ergun was the Chief Technology Officer from Avande’s inception until his death on August 31, 2017.9 B. Avande’s Formation, Management, and Capital Structure Before Avande was formed, Kato had developed an independent consulting practice to review hospital bills for insurance companies and to perform “prior authorization” services.10 “Prior authorization is a process where physicians and hospitals submit their requests for services” to an insurer so that the insurer may determine if the services requested are medically necessary.11 Toward the end of 2012, seeing a business opportunity, Kato decided to start a company to provide these types of services and recruited Ergun and Evans to join him.12 In April 2013, Kato formed Avande, LLC as a new medical management business to perform prior authorization and hospital billing review services for insurers.13 Ansera Cloud Services, LLC was formed simultaneously to develop,

7 PTO ¶ 14; JX 14 at AVANDE0023353.

8 PTO ¶ 15; Tr. 401 (Kato).

9 PTO ¶¶ 16, 19.

10 Tr. 402-03 (Kato).

11 Tr. 403-04 (Kato).

12 Tr. 404-07 (Kato)

13 JX 14; Tr. 405-06 (Kato).

operate, and manage the internet “cloud application” and related technology that Avande LLC would use to serve its clients.14 Kato, Evans, and Ergun divided up their responsibilities into three areas.

Kato, as the Chief Medical Officer, “was the medical guy” who had the client relationships and performed the “medical reviews” for clients.15 Ergun, as the Chief Technology Officer, was responsible for information technology, including “building out systems” for the Company.16 Evans, as the CEO, described his responsibilities as extending to anything that Kato and Ergun did not do, which included administrative and financial matters.17 For a time, Evans oversaw financial matters as the Chief Financial Officer, but beginning in 2015, Evans engaged an outside CFO service called NowCFO and used a CPA (Ronald J. Ruttenberg) to produce its year-end financial reports.18 In February 2016, Kato, Evans, and Ergun decided to restructure Avande LLC and convert it into a Delaware corporation.19 On February 23, 2016, pursuant to the terms of a Stock Purchase Agreement, all the membership interests in Avande LLC

14 Tr. 408-09 (Kato); Tr. 152 (Evans).

15 Tr. 14 (Evans); Tr. 408 (Kato).

16 Tr. 14 (Evans); Tr. 408 (Kato).

17 Tr. 14 (Evans): Tr. 408 (Kato).

18 Tr. 271-72, 384-85 (Evans)

19 Tr. 412-13 (Kato).

and Ansera Cloud Services, LLC were exchanged for shares of Avande, Inc. stock.20 Avande, LLC and Ansera Cloud Services LLC initially operated as wholly-owned subsidiaries of Avande, Inc. but later were merged into Avande, Inc.21 On December 13, 2016, a certificate of cancellation for Avande, LLC was filed with the Delaware Secretary of State and Avande, Inc. assumed all of its rights and obligations.22 After forming Avande, Inc., Kato, Evans, and Ergun served as its directors.23 Five people owned Avande’s common stock at the time, apportioned as follows: Kato owned 43.0108%, Evans owned 30.466%, Ergun owned 23.2975%, and two others, Donna Gentile and Peter Dumich, owned 1.7921% and 1.4337%, respectively.24 The Company’s three officers each resided and worked in a different location: Kato in Los Angeles, Evans in San Francisco, and Ergun circulated between Turkey, Mexico and two locations in California—San Diego and Irvine.25 C. Other Businesses Owned and Operated by Avande’s Principals Avande, LLC’s operating agreement permitted managers to engage in outside business ventures.26 This practice continued after the formation of Avande, Inc.

20 PTO ¶¶ 3-4; JX 131 at AVANDE0009345; Tr. 412 (Kato).

21 PTO ¶ 4; Tr. 152-53 (Evans).

22 PTO ¶¶ 5-6.

23 PTO ¶ 14.

24 PTO ¶ 13.

25 Tr. 377 (Evans); Tr. 425 (Kato).

26 JX 14 § 6.7(a).

While working for Avande, Ergun owned and operated Avandel, Inc.

Free access — add to your briefcase to read the full text and ask questions with AI

Avande, Inc. v. Shawn Evans, (Del. Ct. App. 2019).

Avande, Inc. v. Shawn Evans (Avande, Inc. v. Shawn Evans) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Carlson v. Hallinan
925 A.2d 506 (Court of Chancery of Delaware, 2006)
Weinberger v. UOP, Inc.
457 A.2d 701 (Supreme Court of Delaware, 1983)
Thorpe by Castleman v. Cerbco, Inc.
676 A.2d 436 (Supreme Court of Delaware, 1996)
International Telecharge, Inc. v. Bomarko, Inc.
766 A.2d 437 (Supreme Court of Delaware, 2000)
Emerald Partners v. Berlin
726 A.2d 1215 (Supreme Court of Delaware, 1999)
Valeant Pharmaceuticals International v. Jerney
921 A.2d 732 (Court of Chancery of Delaware, 2007)
In Re Walt Disney Co. Derivative Litigation
906 A.2d 27 (Supreme Court of Delaware, 2006)
Sample v. Morgan
914 A.2d 647 (Court of Chancery of Delaware, 2007)
In Re Walt Disney Co. Derivative Litigation
907 A.2d 693 (Court of Chancery of Delaware, 2005)
Nakahara v. NS 1991 American Trust
718 A.2d 518 (Court of Chancery of Delaware, 1998)
In re Trados Inc. Shareholder Litigation
73 A.3d 17 (Court of Chancery of Delaware, 2013)
In re Orchard Enterprises, Inc.
88 A.3d 1 (Court of Chancery of Delaware, 2014)
Bodley v. Jones
59 A.2d 463 (Supreme Court of Delaware, 1947)